VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
XTLB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
XTLBXTL Biopharmaceuticals Ltd.
$1.55$682157
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksXTLBPrice History

XTLB logoXTL Biopharmaceuticals Ltd. (XTLB) Stock Price History

Historical prices from 2005 to 2026

$1.55-0.16  (-9.36%)close Nov 6
Returns
1M
-23.3%
3M
-46.0%
YTD
-35.4%
1Y
-61.3%
3Y
-22.4%
5Y
-36.9%
ATH$2,400.00Sep 2005-99.9%
ATL$1.55Nov 2026pre-split
Avg Vol (50D)7K/ day
52-Week Range$1.55 — $5.64
LowCurrent: $1.55High

Loading 10-year price history...

XTLB Historical Performance

1 YearTotal Return
-61.3%
Price: -61.3%
3 YearsTotal Return
-53.3%
CAGR: -22.4%
Price: -53.3%
5 YearsTotal Return
-90.0%
CAGR: -36.9%
Price: -90.0%
YTD
-35.4%

XTLB Annual Returns

Year-by-year price performance · 2005–2026

Best+327.3%2010
Worst-98.3%2008
Up years6/22
2005-32.2%
2006-65.4%
2007+5.2%
2008-98.3%
2009+66.7%
2010+327.3%
2011-24.0%
2012+81.0%
2013-60.9%
2014-36.5%
2015-27.3%
2016-57.7%
2017-29.5%
2018-29.1%
2019-22.2%
2020+133.1%
2021-20.9%
2022-58.0%
2023-16.5%
2024+107.7%
2025-70.6%
2026-17.5%
2005 annual price return
-32.2%
2006 annual price return
-65.4%
2007 annual price return
+5.2%
2008 annual price return
-98.3%
2009 annual price return
+66.7%
2010 annual price return
+327.3%
2011 annual price return
-24.0%
2012 annual price return
+81.0%
2013 annual price return
-60.9%
2014 annual price return
-36.5%
2015 annual price return
-27.3%
2016 annual price return
-57.7%
2017 annual price return
-29.5%
2018 annual price return
-29.1%
2019 annual price return
-22.2%
2020 annual price return
+133.1%
2021 annual price return
-20.9%
2022 annual price return
-58.0%
2023 annual price return
-16.5%
2024 annual price return
+107.7%
2025 annual price return
-70.6%
2026 annual price return
-17.5%
LessMore
Alpha vs S&P 500
1Y-70.9%
3Y-38.9%
5Y-45.0%

Price returns only.

Download Historical Data

5,328 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

XTLB Stock Price Trajectory (2005–2026)

As of November 8, 2026, XTL Biopharmaceuticals Ltd. (XTLB) trades at $1.55, representing a -61.3% return over the past year. The stock has delivered a -90.0% total return over five years (-36.9% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $2,400.00 on September 1, 2005. From this peak, XTLB has corrected -99.9%, currently trading 42% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers NRXP (-10.9% 1Y), SIGA (-62.1% 1Y), and BFRI (-28.6% 1Y), XTLB has underperformed the peer group average. Compare XTLB vs NRXP →

XTLB Historical Price Data · from 2005

Rows 1–50 of 5,328
Date Open High Low Close Volume Change %
2026-11-061.671.681.551.554K-9.36%
2026-11-051.611.761.551.717K+0.59%
2026-11-041.761.801.611.7010K-1.73%
2026-11-031.801.861.661.736K+1.76%
2026-11-021.611.861.611.7013K+5.59%
2026-10-301.651.691.601.619K-8.52%
2026-10-291.901.901.761.767K-12.44%
2026-10-281.782.031.652.018K+11.05%
2026-10-271.781.811.751.812K-0.55%
2026-10-261.891.891.821.824K-9.90%
2026-10-231.972.021.972.024K+2.54%
2026-10-221.861.971.781.9710K+5.35%
2026-10-211.941.941.871.874K-3.61%
2026-10-201.941.941.941.941K-1.02%
2026-10-191.891.961.891.962K0.00%
2026-10-161.942.011.941.962K+2.62%
2026-10-151.862.011.861.917K+1.60%
2026-10-141.921.921.861.882K-5.05%
2026-10-131.931.981.881.984K+3.13%
2026-10-121.951.951.921.922K-3.03%
2026-10-091.982.031.981.989K-0.50%
2026-10-081.982.031.971.9914K+0.51%
2026-10-072.022.051.981.9828K-1.98%
2026-10-062.172.262.022.0237K-7.34%
2026-10-052.202.362.172.1813K+0.93%
2026-10-022.172.212.162.167K+1.41%
2026-10-012.422.422.132.137K-7.39%
2026-09-302.332.332.302.302K+4.07%
2026-09-292.262.282.112.2124K-0.90%
2026-09-282.272.442.232.234K+1.36%
2026-09-252.302.432.202.201K-8.71%
2026-09-242.222.502.222.4113K+9.55%
2026-09-232.392.402.202.203K-7.56%
2026-09-222.382.382.382.381250.00%
2026-09-212.272.382.192.38750-0.83%
2026-09-182.402.402.402.4090.00%
2026-09-172.402.402.352.403K+0.42%
2026-09-162.482.492.382.392K-4.40%
2026-09-152.402.502.282.505K+2.88%
2026-09-142.472.512.402.432K-5.08%
2026-09-112.482.562.472.562K+1.59%
2026-09-102.522.522.522.5210.00%
2026-09-092.442.562.402.526K-0.40%
2026-09-082.532.532.532.537000.00%
2026-09-042.432.532.432.532K+1.20%
2026-09-032.602.602.462.503K-6.02%
2026-09-022.352.692.322.6633K+14.66%
2026-09-012.442.472.322.324K-6.83%
2026-08-312.512.582.482.498K+0.81%
2026-08-282.512.702.472.478K-4.26%
…
Consensus & Technical Research Suite
Open XTLB Terminal

XTLB Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

XTLB — Frequently Asked Questions

Quick answers to the most common questions about buying XTLB stock.

How has XTLB stock performed recently?

XTLB declined -61.3% over the past year, below its 5-year annualized CAGR of -36.9%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is XTLB's all-time high price?

XTL Biopharmaceuticals Ltd. reached $2400.00 on 2005-09-01. The 52-week high is $5.64. Current 1-year return of -61.3% places the stock further from historical peaks.

Where can I download XTLB historical price data?

This page provides XTLB daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2005-2026, downloadable in CSV format.

486 data points · sampled from 5,328